Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development.
about
Modulation of the Chlamydia trachomatis in vitro transcriptome response by the sex hormones estradiol and progesterone.Immune regulation of a chronic bacteria infection and consequences for pathogen transmission.Assessing the presence of Chlamydia trachomatis genome in pregnant women with spontaneous abortion using polymerase chain reaction method in Yasuj: First report from Southwest of Iran.STI-GMaS: an open-source environment for simulation of sexually-transmitted infections.Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans.Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challengeUse of a Guinea pig-specific transcriptome array for evaluation of protective immunity against genital chlamydial infection following intranasal vaccination in Guinea pigs.The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization.Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infectionUpdate on the impact of Chlamydia trachomatis infection on male fertility.Public health policies and management strategies for genital Chlamydia trachomatis infection.Blockade of epithelial membrane protein 2 (EMP2) abrogates infection of Chlamydia muridarum murine genital infection modelFormulation, characterization, and expression of a recombinant MOMP Chlamydia trachomatis DNA vaccine encapsulated in chitosan nanoparticles.Classical and Molecular Methods for Evaluation of Chlamydia trachomatis Infection in Women with Tubal Factor Infertility.Chlamydia trachomatis infection modulates trophoblast cytokine/chemokine production.Host immune responses to chlamydial inclusion membrane proteins B and C in Chlamydia trachomatis infected women with or without fertility disordersPattern recognition at the maternal-fetal interface.Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.Exploration of testing practices and population characteristics support an increase in chlamydia positivity in Tasmania between 2001 and 2010.Novel HLA-B27-restricted epitopes from Chlamydia trachomatis generated upon endogenous processing of bacterial proteins suggest a role of molecular mimicry in reactive arthritis.Usefulness of 11C-choline positron emission tomography for genital chlamydial infection assessment in a BALB/c murine model.Rab11-family of interacting protein 2 associates with chlamydial inclusions through its Rab-binding domain and promotes bacterial multiplication.Effects of inoculating dose on the kinetics of Chlamydia muridarum genital infection in female mice.Localization of TLR2 and MyD88 to Chlamydia trachomatis inclusions. Evidence for signaling by intracellular TLR2 during infection with an obligate intracellular pathogen.NOD protein expression and function in first trimester trophoblast cells.
P2860
Q31021339-9BA261C8-B3E5-4177-83A0-664212721933Q33672341-C4DEB533-208A-487B-92FC-3E97E7E7DDF0Q33796237-68082BF5-6182-4667-AE39-5AE970E579ECQ33818678-CDE815AC-B03B-4832-9ADD-D59EE30ECED6Q34009698-A2E41A52-115B-4745-A94A-783651394B05Q34130795-06AFE703-C0F9-429E-B746-6442F772163BQ34680475-454385DE-B499-43DC-B3D6-9BCA15464B27Q35000987-44E4D54D-B58F-41EF-AB05-FD3D07C7592CQ35550138-8A618761-848C-4772-BA9B-2438D981675CQ35661023-64126BB6-5E6F-465B-8A91-D1542503065FQ35727770-4D14C677-1DA9-4C91-B1EE-9A5798157F28Q35876314-C642E29A-4C3A-4277-B240-13045E76F937Q36852020-19DC2E98-C294-45D3-8D04-8BEEA15FF183Q37035405-849B57BE-9218-42C8-BBD5-5E120102AFD7Q37120656-BB6D385D-5EEE-482D-AA38-81AD6EFF5E08Q37226052-2D10E4E9-2014-49DD-B7BF-E4C116CCA065Q37248430-84B5F97D-7DA2-4B38-9A6A-C2447C05BDBCQ37835358-B726D7AC-D69C-4337-B0C7-C66AE0EB95C2Q37838149-1004DC1B-A733-4DC2-8A92-041275255E7DQ37846210-7F6C4F48-138E-4D3C-8E3D-DDB39F802DB2Q37847198-0BE99163-6F3E-47A5-B304-341546FC5F4EQ37848028-567D1753-EA11-4CCF-A725-C7B0FC259651Q37855543-38D081F7-321F-4447-B693-434689595885Q37863553-8E5842DD-E06A-447A-BA02-B438E2D8AAA7Q40199197-0A51D165-C9F9-4B53-87F5-C4B36EB6A7A3
P2860
Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Chlamydia trachomatis infectio ...... pects for vaccine development.
@ast
Chlamydia trachomatis infectio ...... pects for vaccine development.
@en
Chlamydia trachomatis infectio ...... pects for vaccine development.
@nl
type
label
Chlamydia trachomatis infectio ...... pects for vaccine development.
@ast
Chlamydia trachomatis infectio ...... pects for vaccine development.
@en
Chlamydia trachomatis infectio ...... pects for vaccine development.
@nl
prefLabel
Chlamydia trachomatis infectio ...... pects for vaccine development.
@ast
Chlamydia trachomatis infectio ...... pects for vaccine development.
@en
Chlamydia trachomatis infectio ...... pects for vaccine development.
@nl
P1476
Chlamydia trachomatis infectio ...... pects for vaccine development.
@en
P2093
Beagley KW
P356
10.1016/S0165-0378(00)00069-3
P50
P577
2000-08-01T00:00:00Z